| Patrick Cahill, PHARMD | |
|
97 Morrisville Plz, Morrisville, VT 05661-4473 | |
| (802) 888-5244 | |
| Not Available |
| Full Name | Patrick Cahill |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 97 Morrisville Plz, Morrisville, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427519180 | NPI | - | NPPES |
| 033.0112104 | Other | VT | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0112104 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Cahill, PHARMD 1930 Shaw Mansion Rd, Waterbury Center, VT 05677-8256 Ph: () - | Patrick Cahill, PHARMD 97 Morrisville Plz, Morrisville, VT 05661-4473 Ph: (802) 888-5244 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced the presentation of preclinical data at Digestive Disease Week 2012, in San Diego, which demonstrates the protective effect of cobiprostone against epithelial barrier dysfunction in models of non-steroidal anti-inflammatory drug (NSAID)-induced gastric mucosal injury.
Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.
Scientist have identified a link between exposure to high levels of estrogen sex hormones in the womb and the likelihood of developing autism. The findings are published today in the journal Molecular Psychiatry.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers from the Institut de Pharmacologie et he Biologie Structurale (CNRS/Université Toulouse III - Paul Sabatier) have recently elucidated one of these mechanisms in prostate cancer, one of the most common cancers in men: in obese patients, the adipose tissue surrounding the prostate gland facilitates the propagation of tumor cells outside the prostate.
› Verified 8 days ago
Dr. Matthew Flo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 97 Morrisville Plz, Morrisville, VT 05661 Phone: 802-888-5244 Fax: 802-888-6981 | |
Sharon Zhou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Congress Street, Morrisville, VT 05661 Phone: 802-888-2226 | |
Devon Lautenschlager, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Congress Street, Morrisville, VT 05661 Phone: 802-888-2226 | |
Steven Collins, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 97 Morrisville Plz, Morrisville, VT 05661 Phone: 802-888-5244 | |
Mr. Anil K Vinjamuri, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Congress Street, Morrisville, VT 05661 Phone: 802-888-2226 Fax: 802-888-4719 | |
Adam Russell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 Congress St, Morrisville, VT 05661 Phone: 802-888-2226 | |
Tyler Prescott, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 97 Morrisville Plz, Morrisville, VT 05661 Phone: 802-888-5244 Fax: 802-888-6981 |